SLRN
ACELYRIN, INC. Common Stock
NASDAQ: SLRN · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.00% today
Updated 2026-04-30
Market cap
$229.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.69
Dividend yield
—
52W range
$2 – $3
Volume
4.1M
ACELYRIN, INC. Common Stock (SLRN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $102.30M | $332.96M | $742.69M | $491.14M |
| Cash & equivalents | $102.24M | $278.56M | $218.10M | $73.89M |
| Current assets | $102.30M | $330.22M | $736.64M | $480.99M |
| Total liabilities | $144.36M | $444.35M | $86.35M | $32.85M |
| Current liabilities | $11.74M | $32.83M | $85.16M | $26.58M |
| Long-term debt | — | — | — | — |
| Shareholder equity | $-42.06M | $-111.39M | $656.34M | $458.29M |
| Retained earnings | $-42.31M | $-250.11M | $-488.72M | $-736.95M |
| Accounts receivable | — | $388000.00 | $4.75M | $30.23M |
| Inventory | — | $-388000.00 | $8.85M | — |
| Goodwill | — | — | — | — |